| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.054 | 0.3 |